PT1023903E - Utilizacao de bacterias vivas atenuadas para o fabrico de uma vacina submucosa - Google Patents

Utilizacao de bacterias vivas atenuadas para o fabrico de uma vacina submucosa

Info

Publication number
PT1023903E
PT1023903E PT00200216T PT00200216T PT1023903E PT 1023903 E PT1023903 E PT 1023903E PT 00200216 T PT00200216 T PT 00200216T PT 00200216 T PT00200216 T PT 00200216T PT 1023903 E PT1023903 E PT 1023903E
Authority
PT
Portugal
Prior art keywords
vaccine
manufacture
submucose
atenuated
live bacteria
Prior art date
Application number
PT00200216T
Other languages
English (en)
Inventor
Antonius Arnoldus Chris Jacobs
Danny Goovaerts
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of PT1023903E publication Critical patent/PT1023903E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/82—Viral vaccine for equine species, e.g. horses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/829—Bacterial vaccine for equine species, e.g. horses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PT00200216T 1999-01-26 2000-01-20 Utilizacao de bacterias vivas atenuadas para o fabrico de uma vacina submucosa PT1023903E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99200202 1999-01-26

Publications (1)

Publication Number Publication Date
PT1023903E true PT1023903E (pt) 2004-04-30

Family

ID=8239828

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00200216T PT1023903E (pt) 1999-01-26 2000-01-20 Utilizacao de bacterias vivas atenuadas para o fabrico de uma vacina submucosa

Country Status (10)

Country Link
US (2) US20040120970A1 (pt)
EP (1) EP1023903B1 (pt)
JP (1) JP4339978B2 (pt)
AT (1) ATE257713T1 (pt)
AU (1) AU761515B2 (pt)
CA (1) CA2296965A1 (pt)
DE (1) DE60007668T2 (pt)
DK (1) DK1023903T3 (pt)
ES (1) ES2214217T3 (pt)
PT (1) PT1023903E (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0315323D0 (en) 2003-07-01 2003-08-06 Royal Veterinary College Vaccine composition
US9023366B2 (en) 2003-07-01 2015-05-05 The Royal Veterinary College Vaccine composition for vaccinating dogs against canine infectious respiratory disease (CIRD)
US20100329993A1 (en) 2007-06-29 2010-12-30 Hiroyuki Yoneyama Method of fixing and expressing physiologically active substance
GB0801326D0 (en) * 2008-01-24 2008-03-05 Animal Health Trust Vaccines
KR101210082B1 (ko) * 2010-10-15 2012-12-07 주식회사 동방 돼지 다발성 장막염 예방용 백신 조성물 및 그 제조방법
KR101694676B1 (ko) * 2015-12-10 2017-01-10 우진 비앤지 주식회사 말 선역 질병원인 국내 분리 스트렙토코커스 이콰이 균주 및 이를 포함하는 백신
WO2020032232A1 (ja) 2018-08-10 2020-02-13 Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 バクテリオファージ剤
CN112973157A (zh) * 2021-02-04 2021-06-18 广西田东锦盛化工有限公司 一种用于氯碱生产的盐水浓缩装置
CN113244664A (zh) * 2021-05-12 2021-08-13 伍俊雄 一种用于疫苗破乳及分离的装置

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2033223B (en) * 1978-09-01 1983-09-14 Secr Social Service Brit Antigen fromstreptococcus mutans for protection against dental caries
JPS6037734B2 (ja) 1978-10-12 1985-08-28 住友電気工業株式会社 管状臓器補綴材及びその製造方法
JPS58500948A (ja) 1981-06-19 1983-06-09 イギリス国 「う」蝕症からの保護
IE940698L (en) 1984-04-05 1985-10-05 Univ Missouri Vaccine and serum for endotoxin associated disease and method of preparing same as well as to methods of immunization and treatment of such disease and to a detoxified endotoxin and bacterial mutant
AR241545A1 (es) * 1985-07-12 1992-08-31 Cornell Res Foundation Inc Un metodo para preparar una cepa de s. equi avirulenta a.t.c.c. 53186 para equinos.
BE1008103A3 (fr) 1994-04-22 1996-01-16 Pantochim Sa Procede de preparation de catalyseurs au vanadium et phosphore et leur utilisation pour la production d'anhydride maleique.
ZA97452B (en) 1996-01-25 1997-08-15 Trinity College Dublin Streptococcus equi vaccine.
US5895756A (en) 1997-04-11 1999-04-20 The Board Of Trustees Of The University Of Texas System Non-antibiotic system for selection of recombinant mycobacteria
US6682745B1 (en) * 1998-07-28 2004-01-27 Christiaan Antonius Arnoldus Jacobs Use of bacterium for manufacture of a vaccine
CA2243730C (en) * 1997-07-29 2009-12-22 Akzo Nobel N.V. Streptococcus equi vaccine
US6344201B1 (en) 1998-03-31 2002-02-05 Anthony T. Maurelli Methods of identifying bacterial genes that are incompatible with bacterial pathogenicity, and the use of such genes, such as cadA, to reduce pathogenicity in a bacteria or to combat pathogenic bacterial infections

Also Published As

Publication number Publication date
CA2296965A1 (en) 2000-07-26
AU1355700A (en) 2000-07-27
EP1023903A1 (en) 2000-08-02
DE60007668D1 (de) 2004-02-19
ATE257713T1 (de) 2004-01-15
US20040120970A1 (en) 2004-06-24
DE60007668T2 (de) 2004-12-02
AU761515B2 (en) 2003-06-05
JP4339978B2 (ja) 2009-10-07
JP2000309542A (ja) 2000-11-07
US8084040B2 (en) 2011-12-27
ES2214217T3 (es) 2004-09-16
US20110123571A1 (en) 2011-05-26
EP1023903B1 (en) 2004-01-14
DK1023903T3 (da) 2004-05-10

Similar Documents

Publication Publication Date Title
CY1113766T1 (el) Παραγωγα ινδολιδονης για την θεραπεια ή προληψη ινωτικων ασθενειων
EA200300171A1 (ru) Циклопентаноиндолы, композиции, содержащие данные соединения, и способы лечения
UY26545A1 (es) " alimento para mascotas para tratar especies de helicobacter en mascotas."
GT200000190A (es) Procedimiento para la obtencion de 1,2,3,4-tetrahidroquinolinas-4-carboxiamino-2-sustituidas.
ATE140687T1 (de) Bakterientötende zweiwertiges silber enthaltende zusammensetzungen
CU23006A3 (es) Nuevos ésteres derivados de compuestos fenil-ciclonuevos ésteres derivados de compuestos fenil-ciclohexil sustituidos hexil sustituidos
DE69526854D1 (de) Physikalisch modifizierte abbaubare thermoplastische zusammensetzung
ES2097341T3 (es) Indoles sustituidos como farmacos para el tratamiento del sida.
EA200870564A1 (ru) Новые производные бензотиазинона и их применение в качестве антибактериальных средств
PT1023903E (pt) Utilizacao de bacterias vivas atenuadas para o fabrico de uma vacina submucosa
SE8100978L (sv) Kinolinkarboxylsyraderivat och sett for framstellning derav
UY26256A1 (es) Amidas de ácidos carboxílicos, medicamentos que contienen estos compuestos, su utilización y su preparación
CY1117237T1 (el) Συνθεσεις σταθερων τιακουμυκινων
UY26929A1 (es) Polipéptidos antiangiogénicos y métodos para inhibir la angiogénesis
ATE368023T1 (de) Hydroxydiphenyletherverbindungen
ES2084339T3 (es) Tetrahidropiridinas e hidroxipiperidinas sustituidas utiles como agentes para el sistema nervioso central.
CO5190657A1 (es) Procedimiento para obtener plantas con un mayor contenido de flavonoides y constituyentes fenolicos
ATE269104T1 (de) Salmonella impfstoff, der keinen antikörper gegen flagellin oder gegen flagella induziert
BR0110087A (pt) Compostos para modular proliferação celular
AR030735A1 (es) Un procedimiento para la produccion de un extracto de champinon natural
NO20014240D0 (no) C16-umettede FP-selektive prostaglandinanaloger
UY26265A1 (es) Compuestos calciolíticos
ES2163220T3 (es) Dioxacicloalcan-8-ona.
DK0548103T3 (da) Anvendelse af pyridylmethylsulfinyl-1H-benzimidazolderivater til behandling af sygdomme, der er fremkaldt af Helicobacter-bakterier
PT894500E (pt) Vacina para streptococcus equi